CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Blood ; 103 (2004), 5. - S. 1595-1601. - ISSN 0006-4971
- Keyword
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Event
-
Veröffentlichung
- (where)
-
Konstanz
- (who)
-
Bibliothek der Universität Konstanz
- (when)
-
2011
- Creator
-
Scandella, Elke
Men, Ying
Legler, Daniel F.
Gillessen, Silke
Prikler, Ladislav
Ludewig, Burkhard
Groettrup, Marcus
- URN
-
urn:nbn:de:bsz:352-166780
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scandella, Elke
- Men, Ying
- Legler, Daniel F.
- Gillessen, Silke
- Prikler, Ladislav
- Ludewig, Burkhard
- Groettrup, Marcus
- Bibliothek der Universität Konstanz
Time of origin
- 2011
Other Objects (12)
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit
Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation : enhanced T cell stimulatory capacity despite IDO
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
No evidence for immunoproteasomes in chicken lymphoid organs and activated lymphocytes
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes